© CEOCFO Magazine -
CEOCFO Magazine, PO Box 340
Palm Harbor, FL 34682-
Phone: 727-
Email: info@ceocfocontact.com
Search
Business Services | Solutions
Medical | Biotech
Cannabis | Hemp
Banking | FinTech | Capital
Government Services
Public Companies
Industrial | Resources
Clean Tech
Global | Canadian
Lynn Fosse, Senior Editor
Steve Alexander, Associate Editor
Bud Wayne, Marketing
& Production Manager
Christy Rivers -
Print -
Valor: a trusted Compounding Pharmacy providing Custom Compounded Medications for Patients with Unique Medication Needs
Rick Niemi
CEO
Valor Compounding Pharmacy
Contact:
510-
Rick Niemi
916-
Interview conducted by:
Lynn Fosse, Senior Editor
CEOCFO Magazine
Published – August 17, 2020
CEOCFO: Mr. Niemi, what is Valor Compounding Pharmacy?
Mr. Niemi: Valor is a 503a licensed compounding pharmacy, with a team of 30+, that makes custom compounded medications for patients with unique medication needs. Offering both sterile and non-
CEOCFO: Do doctors usually get it right or is it trial and error?
Mr. Niemi: Doctors who regularly prescribe compounds as part of their practice have a good understanding of formulas and treatment options. When needed, our pharmacists consult directly with doctors to provide options for consideration based on patients’ needs. We’re an extension of the care team and work together with the doctor and their staff to help their patients the best we can. When we make bio-
CEOCFO: What is the marketplace? How common is the need for compounding?
Mr. Niemi: That is a great question! There is definitely a market for compounding, and we see it growing into the future. For anti-
CEOCFO: What is involved in creating medication with specific requirements for an individual? What are the steps and what are some of the challenges? Is it picking bottles off the shelf? Is it the old mortar and pestle that drugstores used years ago?
Mr. Niemi: Definitely the mortar and pestle method, but with major technological advancements in systems, equipment, training, and quality. To answer the first part of your question, we adhere to strict processes, procedures, and documentation when making medications at Valor. Regulatory compliance is the culture at Valor and the focus in everything we do. Each medication made comes with a standard operating procedure that must be followed to a T. As a data driven company, we measure just about everything to maximize ROI throughout the departments at Valor. In the drug making process, it’s very important to be efficient, and using the right equipment and machinery helps grow the business cost effectively. Valor utilizes process improvement techniques, technology and software to ensure a strong emphasis on quality assurance and controls.
CEOCFO: Is there a shelf life that might be different from a standard medication or cream? Does it vary product to product?
Mr. Niemi: That is a great question! For prescriptions we get at CVS or Rite Aid, they come with an expiration date. That’s the most common term we’re all familiar with. In compounding it’s referred to as BUD, or “beyond use date”. Different medications in different forms come with a specific BUD, or length of time the medication is to be used. In the case when a prescriber or group wants a medication to last longer for their patient base, the item can be tested for a longer BUD. When the test results come back successful, we can extend the life of that compound’s use for all Valor’s patients.
CEOCFO: Why is it worth it? Why go through all these hoops?
Mr. Niemi: Because not everyone can get better taking the same medication. There are many situations where a person needs a medication tailored just for their needs. People are different. We make quality custom compounds to address that difference. Whether it’s making a medication to help a patient balance their hormone levels, or helping a couple attempt to have a baby, we’re here for them. Someone may be ready to go off opioids and give topical pain medications a try, or it might be that person who’s been living with anxiety and is finally feeling better after the doctor prescribed a treatment that made all the difference. Compounding is a niche market and we have a competitive offering, not just in our product making, but in the partnerships we create. We are truly an extension of the care team and provide additional measurable value as consultants in all aspects of working with prescribers, medical groups, researchers, health systems, and other clients we work with. We’re not a reactive pharmacy fulfiller, we’re more so a proactive partner in patient care and customer service. Any pharmacy can claim to make a high-
CEOCFO: Would you tell us about Propel? What does that bring to the table for Valor?
Mr. Niemi: Propel is a quality assurance management system that our President and Chief Pharmacy Officer, Christine Stephanos, learned of and recommended we implement. The goal was to ensure strong adherence to our quality assurance process and documentation through a transparent and electronic system at Valor. Compounding pharmacy is a very rewarding yet serious business. Clear communication and thorough training of our staff is a key foundation for success at Valor.
Propel gives our business an added level of increased confidence and the assurance that the work done at Valor, will more than satisfy the bodies that govern our industry. Propel gives us the infrastructure needed to track the necessary documentation needed to support what we do and how we do it, and further serves as an aid to our continuous performance improvement mission.
CEOCFO: Have you found it difficult to source ingredients these days?
Mr. Niemi: Most recently, Hydroxychloroquine was in short supply. With the help of Professional Compounding Centers of America (PCCA), Valor was able to secure the ingredients needed to make the medication and ship to patients suffering from lupus and rheumatoid arthritis throughout states we are licensed in the US. This is a chronically taken medication, so we made every effort to supply the medication to those who were having trouble finding it, where a valid prescription for it was presented. Outside of hydroxychloroquine, we’ve haven’t had sourcing issues obtaining ingredients from our suppliers. However, there is some concern that a large part of the pharmaceutical industry’s supply chain is found internationally. On a personal note, I think our country relies too much on drug ingredients made outside of the United States, and that needs to change!
CEOCFO: How are you educating the public and medical community, or any stakeholders that could or should be interested in Valor, about the company and what you can do?
Mr. Niemi: I was hoping you would ask that! It would be typical to canvas and speak to doctor’s offices and their staff, set up lunch and learns, and sponsor dinner discussions on a particular topic. Since COVID19 entered our lives, we’ve transformed our business model to be fully functional and known online. Right now, in fact, patients can transfer or refill their prescriptions online, and prescribers can order prescriptions for their patients online as well. We are also expanding our online presence to provide better tools and education for the public.
CEOCFO: Do you see working with organizations, such as the Heart Association, to spread the word about Valor?
Mr. Niemi: You are right on. Partnering with different groups and organizations tied to the disease states or conditions we make medicine for is a no brainer. As an example, we work with professional and college sports teams, orthopedic physicians, sports rehabilitation clinics, and podiatrists to help with our mutual mission to steer away from opioid medication and instead, prescribe patients a topical non-
CEOCFO: Are you seeking funding, investments or partnerships as you move forward?
Mr. Niemi: It is something we would consider at the right time and under the right circumstances. We are not quite at that stage yet. We are still in the process of building out the infrastructure needed in our facility, team, and in the various departments we’re establishing at Valor. The happenings of this year forced us to rethink our 2020 goals and initiatives and we have pivoted nicely and are executing our business plans. We are expanding into other states and acquisitions are a possibility. At the moment, we are looking into and considering the Main Street Lending Program and believe greater things are in store for Valor and its place in the market.
CEOCFO: Why pay attention to Valor Compounding Pharmacy?
Mr. Niemi: Valor is distinguished and set apart. We do more than make medicine; we solve problems.
For the consumer patient, Valor’s brand stands out once they know we’re an option. Offering flat rate pricing, fast turnaround, and free shipping is a game changer. For our commercial clients, we’re a value-
Valor Compounding Pharmacy, Compounding Pharmacy in California, Custom Compounded Medicine, Rick Niemi, Valor: a trusted Compounding Pharmacy providing Custom Compounded Medications for Patients with Unique Medication Needs, CEO Interviews 2020, Medical Companies, Custom medicine compounding pharmacy, custom compounded medications, prescriptions filled ca, compounded medications, including hormone replacement, erectile dysfunction, and ketamin, compounded medications for Physicians, Health Systems, Clinical Researchers, Employers, Pet Medications, Pain Topicals, E-
"Compounding is a niche market and we have a competitive offering, not just in our product making, but in the partnerships we create. We are truly an extension of the care team and provide additional measurable value as consultants in all aspects of working with prescribers, medical groups, researchers, health systems, and other clients we work with.” Rick Niemi
LATEST NEWS